2026 NPPES data Specialist NPI 1679617971 M.D.
Verify on CMS →

Manoj Kantu, M.D.

Specialist in Brooklyn, New York.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,567 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 749 beneficiaries · Specialist avg: 2K
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 84 pts below national avg 83.5 · Penalty band
Industry payments
$634.24
28 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Manoj Kantu, M.D. reported a CMS MIPS final score of 0/100 - below the 83.5 national average - and filed 2,234 Medicare Part D claims in 2024.

0/100
MIPS score · -83 vs avg
2K
Part D claims, 2024
98%
generic prescribing
$634.24
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Manoj Kantu, M.D.

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1679617971), first enumerated 02/19/2007.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 2,234 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 0/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $634.24 in reported industry payments (28 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Manoj Kantu, M.D.'s individual license status. Verify directly with the state medical board.

    Source: NYSBPMC annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1679617971 · Specialist

NPI-10 · ENUM-MID · TAX-MEGA · MIPS-LOW · RX-MID · BOOK-MID · PHOTO-FINISH

  • NPI-10 1679617971
  • ENUM-MID 2007
  • TAX-MEGA 70K Specialist
  • MIPS-LOW 0/100
  • RX-MID 2,234
  • BOOK-MID 23,149 in New York
  • PHOTO-FINISH Ahmad Alturjuman, M.… · ±0.0

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Manoj Kantu, M.D.'s MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

0 ≥ 0th percentile 0% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). This entry sits in this band. 10–20: 3,008 measured providers (1%). Above this entry. 20–30: 3,069 measured providers (1%). Above this entry. 30–40: 2,746 measured providers (1%). Above this entry. 40–50: 2,928 measured providers (1%). Above this entry. 50–60: 5,882 measured providers (1%). Above this entry. 60–70: 13,906 measured providers (3%). Above this entry. 70–80: 94,570 measured providers (21%). Above this entry. 80–90: 129,887 measured providers (29%). Above this entry. 90+: 189,403 measured providers (42%). Above this entry. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Manoj Kantu, M.D. sits

This provider among specialist peers

Across the 4,261 specialist providers who report both Medicare Part D prescribing and a MIPS quality score, Manoj Kantu, M.D. writes more Part D claims than 74% of them and scores higher on MIPS quality than 0% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.148.372.496.6Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 90Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 25Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 82Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 63Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 48Point, Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 68Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 22Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 42Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 15Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 37Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 43Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 57Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 12Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 28Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 50Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 55Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 85Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 65Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 77Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 0Manoj Kantu, M.D., Part D claim volume, percentile in specialty: 74 · MIPS quality, percentile: 0
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one specialist peer from a representative sample of 60; the gold marker is Manoj Kantu, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

What does the federal data show about Manoj Kantu, M.D.?

Below national average

NPI registry status

Active

Issued 02/19/2007

NPI 1679617971

Primary specialty

Specialist

High-volume

69,567 US NPIs in this specialty

Medicare Part D claims

2,234 47% vs specialty avg

2024 prescription claims

Specialty avg: 1,524

MIPS final score

0/100 83.5 pts vs avg

Penalty band band

vs 83.5 national avg

Specialty distribution in New York

How Specialist compares to other specialties among New York providers

New York providers
Student in an Organized Heal…8%Registered Nurse5.2%Clinical Social Worker4.9%Social Worker4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse4.3%Specialist4.2%
Largest specialties in New York (% of in-state providers)

Medicare quality performance, MIPS

Manoj Kantu, M.D.'s 2023 MIPS final score plotted against the Specialist national average

Below national average
MIPS Final Score
0/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%0%
MIPS final score (Specialist) - 0/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

2204 VOORHIES AVE
Brooklyn, NY 11235

Provider Details

NPI 1679617971
Specialty Specialist
Credentials M.D.
Gender Male
NPI Issued 02/19/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Measured-score avg: 83.5
0
Quality

Reporting: Individual

Hospital and facility affiliations

Facilities where Manoj Kantu, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NY Center For Ear Nose Throat Sinus Allergy LLP
Brooklyn, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Manoj Kantu, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$634

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - New York NYSBPMC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Manoj Kantu, M.D.. To verify Manoj Kantu, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

Manoj Kantu, M.D. - brand share 2.0%
Specialist average

2% brand-name claims vs 98% generic, on 2,234 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

2,234
Total Claims
$92K
Total Drug Cost
749
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,470.533
Total Day Supply
60,574
Brand vs Generic
2% brand / 98% generic
Brand Drug Cost
$28K
Generic Drug Cost
$63K
Antibiotic Claims
320

Patient Demographics

Average Patient Age
73.3 years
Avg HCC Risk Score
1.26
Gender Split
60% female / 40% male
Age Distribution
<65: 75, 65-74: 362, 75-84: 230, 85+: 82

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Manoj Kantu, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Fluticasone Propionate
520
Ipratropium Bromide
375
Mometasone Furoate
224
Montelukast Sodium
180
Cefdinir
95
Azelastine Hcl
88
Ofloxacin
76
Omeprazole
68
Clarithromycin
53
Methylprednisolone
52

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How Manoj Kantu, M.D. fits within the Specialist landscape nationally.

69,567
Specialist Providers in US
55
States with Specialist
1,524
Avg Claims per Provider

Manoj Kantu, M.D.'s 2,234 claims are above the specialty average of 1,524.

Nationwide Specialist peers with similar MIPS or enrollment year

Two federal-record peer sets for Kantu, both outside New York so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (0 here).

Same NPPES enumeration year (2007)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Specialist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Kantu.

One of 23,149 Specialist providers enrolled in New York, 5 are shown here.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is Manoj Kantu, M.D.'s specialty?
Manoj Kantu, M.D. specializes in Specialist and practices in Brooklyn, New York. Credentials: M.D..
How much does Manoj Kantu, M.D. prescribe under Medicare Part D?
In 2024, Manoj Kantu, M.D. wrote 2,234 Medicare Part D claims totaling $92K in drug costs for 749 beneficiaries.
What is Manoj Kantu, M.D.'s Medicare quality score?
Manoj Kantu, M.D. has a CMS MIPS Final Score of 0/100 (Quality: 0). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Manoj Kantu, M.D. located?
Manoj Kantu, M.D. is located at 2204 VOORHIES AVE, Brooklyn, NY, 11235. Phone: (718) 646-2500.
What is Manoj Kantu, M.D.'s NPI number?
Manoj Kantu, M.D.'s National Provider Identifier (NPI) is 1679617971, issued on 02/19/2007.
Does Manoj Kantu, M.D. prescribe more brand-name or generic drugs?
Manoj Kantu, M.D.'s prescribing is 2% brand-name and 98% generic drugs by claim count, with $28K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,567 Specialist providers across 55 states in the US. The average Specialist provider writes 1,524 Medicare Part D claims per year.
What drugs does Manoj Kantu, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Manoj Kantu, M.D.'s most frequently prescribed drugs include Fluticasone Propionate, Ipratropium Bromide, Mometasone Furoate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Manoj Kantu, M.D. accept Medicare?
Manoj Kantu, M.D. appears in CMS Medicare data with 2,234 Part D claims and 749 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Manoj Kantu, M.D.'s credentials?
Manoj Kantu, M.D.'s NPI is 1679617971 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.